EXON2 OF HIV-2 TAT CONTRIBUTES TO TRANSACTIVATION OF THE HIV-2 LTR BY INCREASING BINDING-AFFINITY TO HIV-2 TAR RNA

被引:20
|
作者
RHIM, H [1 ]
RICE, AP [1 ]
机构
[1] BAYLOR COLL MED,DIV MOLEC VIROL,HOUSTON,TX 77030
关键词
D O I
10.1093/nar/22.21.4405
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human immunodeficiency virus types 1 and 2 (HIV-1 and HIV-2) express related Tat proteins that are encoded in two exons. Tat proteins bind directly to the TAR RNA element contained in the 5' ends of viral transcripts and thereby stimulate transcription through an as yet unidentified mechanism. We have investigated the functional significance of exon2 of the HIV-2 Tat protein by examining properties of proteins consisting of exon1 alone or exon1+2. In transactivation assays in vivo, exon2 modestly increased HIV-2 Tat stimulation of transcription from the HIV-2 long terminal repeat (LTR) but had no effect on transcription from the HIV-1 LTR. in HeLa cells, exon2 increased transactivation of the HIV-2 LTR by approximately three-fold, while in COS and Jurkat cells this value was less than two-fold. In binding assays in vitro, exon2 increased the binding affinity of the HIV-2 Tat protein to HIV-2 TAR RNA. Results with GAL4 fusion proteins and a synthetic promoter containing GAL4 DNA binding sites indicated that exon2 does not contribute to the HIV-2 Tat activation domain. These observations suggest that exon2 of HIV-2 Tat contributes to transactivation of the HIV-2 LTR by increasing the binding affinity to HIV-2 TAR RNA.
引用
收藏
页码:4405 / 4413
页数:9
相关论文
共 50 条
  • [21] HIV-2 INFECTION
    STILLE, W
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1987, 112 (24) : 978 - 978
  • [22] Current HIV-2 Diagnostic Strategy Overestimates HIV-2 Prevalence in China
    Qiu, Maofeng
    Liu, Xin
    Jiang, Yan
    Nkengasong, John N.
    Xing, Wenge
    Pei, Lijian
    Parekh, Bharat S.
    JOURNAL OF MEDICAL VIROLOGY, 2009, 81 (05) : 790 - 797
  • [23] MOLECULAR AND BIOLOGICAL CHARACTERISTICS OF A NOVEL HIV-2 ISOLATE, HIV-2(HOM)
    NICK, S
    DINIZ, CA
    BORN, G
    SAUTER, M
    PEES, HW
    MULLERLANTZSCH, N
    JAHN, G
    VIRUS RESEARCH, 1993, 29 (03) : 267 - 279
  • [24] Towards developing HIV-2 lentivirus-based retroviral vectors for gene therapy: Dual gene expression in the context of HIV-2 LTR and Tat
    Sadaie, MR
    Zamani, M
    Whang, S
    Sistron, N
    Arya, SK
    JOURNAL OF MEDICAL VIROLOGY, 1998, 54 (02) : 118 - 128
  • [25] 90-90-90 for HIV-2? Ending the HIV-2 epidemic by enhancing care and clinical management of patients infected with HIV-2
    Gottlieb, Geoffrey S.
    Raugi, Dana N.
    Smith, Robert A.
    LANCET HIV, 2018, 5 (07): : E390 - E399
  • [26] NUCLEOTIDE-SEQUENCE OF THE HIV-2 EHO GENOME, A DIVERGENT HIV-2 ISOLATE
    GALABRU, J
    REYCUILLE, MA
    HOVANESSIAN, AG
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (07) : 873 - 874
  • [27] RECOMBINANT PEPTIDES DERIVED FROM THE ENVELOPE OF HIV-2 IN THE SERODIAGNOSIS OF HIV-2 INFECTIONS
    OBERHUBER, W
    SCHULZ, TF
    HOFBAUER, JM
    HENGSTER, P
    LARCHER, C
    WACHTER, H
    DIERICH, MP
    IMMUNOBIOLOGY, 1988, 178 (1-2) : 67 - 67
  • [28] False negative anti-HIV-1 HIV-2 ELISAs in acute HIV-2 infection
    Christiansen, CB
    Jessen, TE
    Nielsen, C
    StaunOlsen, P
    VOX SANGUINIS, 1996, 70 (03) : 144 - 147
  • [29] Plasma and tissue HIV-1 and HIV-2 viral load in HIV-2 and dual HIV-1/HIV-2 infected individuals: Implications for starting HAART
    Schutten, M
    van der Ende, ME
    Tenner-Racz, K
    Racz, P
    Niesters, HGM
    Osterhaus, ADME
    AIDS, 2000, 14 : S3 - S3
  • [30] HIV-2 infection and chemokine receptors usage - Clues to reduced virulence of HIV-2
    Azevedo-Pereira, JM
    Santos-Costa, Q
    Moniz-Pereira, J
    CURRENT HIV RESEARCH, 2005, 3 (01) : 3 - 16